This Australian company, Noxopharm, has had some success in trials with its anti-inflammatory drug, Veyonda. Now, it looks like there might be some crossover benefits in Covid-19 treatment (see link):
smallcaps.com.au/noxopharm-...
Don't know if this drug might be of benefit to those of us hoping to delay/suppress recurrence; the PCa trials for Veyonda have focused on the sickest patients. While we're waiting for this drug to make it's way through the approval process, does anyone see a downside for using anti-inflammatory supplements?